COSMO Pharmaceuticals SA (0RGI) — Cash Flow-to-Debt Ratio
COSMO Pharmaceuticals SA (0RGI) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of £-7.38 Million could theoretically repay 0% of its total liabilities (£121.91 Million) in one year. See 0RGI financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
COSMO Pharmaceuticals SA Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for COSMO Pharmaceuticals SA across 22 annual periods. For the full cash flow conversion analysis, see 0RGI operating cash flow.
Annual Cash Flow-to-Debt Ratio for COSMO Pharmaceuticals SA (2004–2025)
Year-by-year debt coverage analysis for COSMO Pharmaceuticals SA. Check 0RGI operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBP) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | £-11.62 Million | £123.36 Million | ▼ -108.2% |
| 2024 | 1.15x | £162.41 Million | £141.68 Million | ▲ +326.0% |
| 2023 | 0.27x | £33.62 Million | £124.94 Million | ▲ +142.0% |
| 2022 | 0.11x | £32.89 Million | £295.80 Million | ▲ +158.3% |
| 2021 | 0.04x | £12.61 Million | £292.88 Million | ▼ -35.0% |
| 2020 | 0.07x | £12.98 Million | £196.04 Million | ▲ +167.3% |
| 2019 | -0.10x | £-18.85 Million | £191.43 Million | ▼ -75.2% |
| 2018 | -0.06x | £-10.16 Million | £180.83 Million | ▲ +83.4% |
| 2017 | -0.34x | £-9.43 Million | £27.86 Million | ▼ -143.6% |
| 2016 | 0.78x | £21.69 Million | £27.92 Million | ▲ +167.9% |
| 2015 | -1.14x | £-39.26 Million | £34.30 Million | ▼ -226.3% |
| 2014 | 0.91x | £66.45 Million | £73.33 Million | ▲ +155.2% |
| 2013 | 0.36x | £8.11 Million | £22.85 Million | ▼ -57.9% |
| 2012 | 0.84x | £27.76 Million | £32.89 Million | ▲ +9.2% |
| 2011 | 0.77x | £11.29 Million | £14.60 Million | ▲ +232.2% |
| 2010 | 0.23x | £7.79 Million | £33.46 Million | ▼ -29.9% |
| 2009 | 0.33x | £3.88 Million | £11.67 Million | ▲ +138.6% |
| 2008 | -0.86x | £-12.52 Million | £14.53 Million | ▼ -312.9% |
| 2007 | -0.21x | £-2.52 Million | £12.08 Million | ▼ -162.7% |
| 2006 | 0.33x | £6.08 Million | £18.27 Million | ▲ +439.9% |
| 2005 | 0.06x | £1.70 Million | £27.58 Million | ▲ +474.9% |
| 2004 | 0.01x | £261.00K | £24.34 Million | — |